Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Replacement of President & CEO Getinge Group:Joacim Lindoff appointed Acting President & CEO of Getinge Group

Posted on: 23 Aug 16
The Board of Directors of Getinge AB has decided to replace the President & CEO of the Getinge Group, which means that Getinges’ President & CEO Alex Myers is leaving his position. The Board of Directors has appointed Joacim Lindoff as Acting President & CEO. Joacim is currently President of Getinge Surgical Workflows and a member of the Executive Team. The change will be effective as of today. ”The Board of Directors and Alex Myers have different views on the future direction of the Getinge Group and the board has therefore concluded that a replacement of the President & CEO is necessary, says Carl Bennet, Getinge’s Chairman of the Board. Joacim Lindoff has been with Getinge since 1999 and has experience from different senior leading positions within the Group. Joacim recently served as Executive Vice President of the business area Infection Control and has since January 1, 2016, headed up Getinge Surgical Workflows and is a member of the Executive Team. The process to recruit a new President & CEO of the Getinge Group will commence immediately. Kornelia Rasmussen Executive Vice President, Corporate Communications & Brand Management Telefon: +46 10 335 5810 E-post: Getinge Group is a leading global provider of innovative solutions for operating rooms, intensive-care units, hospital wards, sterilization departments, elderly care and for life science companies and institutions. With a genuine passion for life we build quality and safety into every system. Our unique value proposition mirrors the continuum of care, enhancing efficiency throughout the clinical pathway. Based on our first-hand experience and close partnerships, we are able to exceed expectations from customers – improving the every-day life for people, today and tomorrow. The information is such that Getinge AB must disclose in accordance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act.GlobeNewswire

Last updated on: 23/08/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.